Publications GFPC 2021

Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer – Secondary analysis of the randomised pahse 3 CONVERT trial.


Lung Cancer.2021 Mar 153:165-170.

Lien: 10.1016/j.lungcan.2020.03.006


Fabio GomesCorinne Faivre-FinnHitesh MistryAndrea BezjakNicolas PourelPierre FournelJan Van MeerbeeckFiona Blackhall 



Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis


Ther Adv Med Oncol 2021, Vol. 13: 1– 10




Isabelle Monnet, Alain Vergnenègre, Gilles Robinet, Henri Berard, Regine Lamy, Lionel Falchero, Sabine Vieillot, Roland Schott, Charles Ricordel, Stephane Chouabe, Pascal Thomas, Radj Gervais, Anne Madroszyk, Samir Abdiche, Anne Marie Chiappa,Laurent Greillier, Chantal Decroisette, Jean Bernard Auliac and Christos Chouaïd



First-line pembrolizumab with or without platinum doublet chemotherapy in non-small-cell lung cancer patients with PD-L1 expression ≥50%




Renaud Descout, Christos Chouaid, Maurice Perol, Benjamin Besse, Laurent Greillier, Olivier Bylicki, Charles Ricordel, Florian Guisier, Radj Gervais, Roland Schott, Jean-Bernard Auliac, Gilles Robinet & Chantal Decroisette